This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1982.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,708 Years Active: 1982
Title: Klaus-Dirk Schenk: Innovator in Herpes Virus Research
Introduction
Klaus-Dirk Schenk is a notable inventor based in Steinhagen, Germany. He has made significant contributions to the field of virology, particularly in the development of vaccines against herpes simplex virus type 1. His innovative approach has the potential to impact public health positively.
Latest Patents
Klaus-Dirk Schenk holds a patent for a process aimed at producing new mutants of herpes simplex virus type 1. This patent describes a method where the herpes virus is doubly mutated in two steps through treatment with phosphono formic acid and 5-ethyl-2'-desoxyuredine. The result of this process is a weakened pathogenicity of the herpes virus, making it suitable for use as a vaccine.
Career Highlights
Throughout his career, Klaus-Dirk Schenk has focused on virology and vaccine development. His work has been instrumental in advancing the understanding of herpes viruses and their potential applications in medicine. His dedication to research has led to significant advancements in the field.
Collaborations
Klaus-Dirk Schenk has collaborated with notable colleagues, including Kailash K Gauri and Klaus Pressler. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.
Conclusion
Klaus-Dirk Schenk's contributions to herpes virus research exemplify the importance of innovation in the medical field. His patented process for creating weakened virus strains holds promise for future vaccine development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile